State of New Jersey Common Pension Fund D’s Corcept Therapeutics CORT Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69M	Sell	30,956 -1,398	-4%	-$84.4K	0.01%	856
2026 Q1	$1.3M	Sell	32,354 -3,569	-10%	-$133K	0.01%	1384
2025 Q4	$1.25M	Buy	35,923 +558	+2%	+$43.8K	﹤0.01%	1387
2025 Q3	$2.94M	Buy	35,365 +100	+0.3%	+$7.24K	0.01%	786
2025 Q2	$2.59M	Sell	35,265 -1,408	-4%	-$102K	0.01%	799
2025 Q1	$4.19M	Sell	36,673 -4,982	-12%	-$303K	0.02%	586
2024 Q4	$2.1M	Sell	41,655 -15,019	-27%	-$787K	0.01%	1120
2024 Q3	$2.62M	Sell	56,674 -2,313	-4%	-$82.2K	0.01%	832
2024 Q2	$1.92M	Sell	58,987 -61,554	-51%	-$1.69M	0.01%	1118
2024 Q1	$3.04M	Buy	120,541 +22,211	+23%	+$525K	0.01%	1078
2023 Q4	$3.19M	Buy	98,330 +22,322	+29%	+$613K	0.01%	914
2023 Q3	$2.07M	Sell	76,008 -23,288	-23%	-$674K	0.01%	1506
2023 Q2	$2.21M	Sell	99,296 -7,000	-7%	-$161K	0.01%	1528
2023 Q1	$2.3M	Buy	106,296 +17,855	+20%	+$391K	0.01%	1193
2022 Q4	$1.8M	Hold	88,441	–	–	0.01%	1593
2022 Q3	$2.27M	Sell	88,441 -23,779	-21%	-$636K	0.01%	1075
2022 Q2	$2.67M	Hold	112,220	–	–	0.01%	938
2022 Q1	$2.53M	Sell	112,220 -10,588	-9%	-$225K	0.01%	1336
2021 Q4	$2.43M	Sell	122,808 -6,442	-5%	-$131K	0.01%	1585
2021 Q3	$2.54M	Buy	129,250 +13,013	+11%	+$272K	0.01%	1477
2021 Q2	$2.56M	Buy	116,237 +35,514	+44%	+$790K	0.01%	1334
2021 Q1	$1.92M	Sell	80,723 -40,111	-33%	-$1.07M	0.01%	1584
2020 Q4	$3.16M	Sell	120,834 -60,144	-33%	-$1.27M	0.01%	1007
2020 Q3	$3.15M	Buy	180,978 +43,795	+32%	+$698K	0.01%	860
2020 Q2	$2.31M	Buy	137,183 +3,029	+2%	+$42.6K	0.01%	1144
2020 Q1	$1.59M	Hold	134,154	–	–	0.01%	1206
2019 Q4	$1.62M	Sell	134,154 -82,446	-38%	-$1.15M	0.01%	1548
2019 Q3	$3.06M	Buy	+216,600	New	+$2.66M	0.01%	1011

Other funds holding CORT

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

State of New Jersey Common Pension Fund D's CORT Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Corcept Therapeutics (CORT) stake by 4.3% in Q2 2026, selling an estimated $84.4K and leaving 30,956 shares worth $2.69M. The position accounts for 0.01% of the portfolio, ranked #856.

State of New Jersey Common Pension Fund D first reported a position in CORT in Q3 2019 and has held it in 28 quarters since. The position peaked at $4.19M in Q1 2025. 147 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

State of New Jersey Common Pension Fund D held 30,956 shares of Corcept Therapeutics worth $2.69M as of Q2 2026.
State of New Jersey Common Pension Fund D sold 1,398 Corcept Therapeutics shares in Q2 2026, an estimated $84.4K.
Corcept Therapeutics made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #856 holding.
State of New Jersey Common Pension Fund D first reported a position in Corcept Therapeutics in Q3 2019 and has held it in 28 quarters since.
State of New Jersey Common Pension Fund D's Corcept Therapeutics position peaked at $4.19M in Q1 2025.
147 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.